Jove
Visualize
Contact Us

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: A simple goniometer-compatible flow cell for serial synchrotron X-ray crystallography. Corrigendum.

Journal of applied crystallography·2025
Same author

Ultrahigh-mobility microbial cytochrome nanowires generate power from humidity.

Research square·2024
Same author

Outer membrane vesicles and the outer membrane protein OmpU govern <i>Vibrio cholerae</i> biofilm matrix assembly.

mBio·2024
Same author

Time-resolved serial crystallography to track the dynamics of carbon monoxide in the active site of cytochrome <i>c</i> oxidase.

Science advances·2023
Same author

A simple goniometer-compatible flow cell for serial synchrotron X-ray crystallography.

Journal of applied crystallography·2023
Same author

Effects of Radioiodine on the Nasolacrimal System.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 18, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

Effects of amiodarone therapy on thyroid function.

Janna Cohen-Lehman1, Peter Dahl, Sara Danzi

  • 1Department of Medicine, North Shore University Hospital, 350 Community Drive, Manhasset, NY 11030, USA.

Nature Reviews. Endocrinology
|November 26, 2009
PubMed
Summary
This summary is machine-generated.

Amiodarone, an antiarrhythmic drug, can cause thyroid dysfunction due to its iodine content. Dronedarone, a newer alternative, is iodine-free and associated with fewer adverse effects, making it a safer option for patients at risk of thyroid issues.

Related Experiment Videos

Last Updated: Jun 18, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Amiodarone, a benzofuran derivative and Class III antiarrhythmic, treats cardiac arrhythmias but is associated with significant thyroid toxicity due to its high iodine content.
  • Thyroid dysfunction, including hypothyroidism and thyrotoxicosis, is a common adverse effect of amiodarone treatment, posing diagnostic and therapeutic challenges.
  • Dronedarone, a structurally similar but iodine-free benzofuran derivative, was developed to mitigate amiodarone's toxicity profile.

Purpose of the Study:

  • To compare the thyroidal safety profiles of amiodarone and dronedarone.
  • To evaluate dronedarone as a potentially safer alternative for patients requiring antiarrhythmic therapy, particularly those susceptible to amiodarone-induced thyroid dysfunction.

Main Methods:

  • Review of clinical studies and pharmacological data comparing amiodarone and dronedarone.
  • Analysis of adverse event profiles, focusing on thyroid-related dysfunction.
  • Comparison of chemical structures and pharmacokinetic properties, including half-life and iodine content.

Main Results:

  • Amiodarone's high iodine content directly contributes to its significant thyroid toxicity.
  • Dronedarone, lacking iodine, demonstrates a substantially lower incidence of thyroid dysfunction in clinical studies.
  • Dronedarone possesses a shorter half-life and fewer overall adverse effects compared to amiodarone.

Conclusions:

  • Dronedarone represents a safer alternative to amiodarone for managing atrial fibrillation and flutter, especially in patients at risk of amiodarone-induced thyroid dysfunction.
  • The absence of iodine in dronedarone's structure is a key factor in its improved thyroid safety profile.
  • Clinicians should consider dronedarone for patients requiring antiarrhythmic therapy to minimize the risk of thyroid-related adverse events.